nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1B1—melanoma	0.448	1	CbGaD
Flutamide—CYP1B1—Docetaxel—melanoma	0.0796	0.203	CbGbCtD
Flutamide—CYP1A1—Dacarbazine—melanoma	0.078	0.199	CbGbCtD
Flutamide—CYP1A2—Carmustine—melanoma	0.0575	0.147	CbGbCtD
Flutamide—CYP1A2—Vemurafenib—melanoma	0.0455	0.116	CbGbCtD
Flutamide—CYP3A4—Temozolomide—melanoma	0.0435	0.111	CbGbCtD
Flutamide—CYP1A2—Dacarbazine—melanoma	0.0349	0.0889	CbGbCtD
Flutamide—CYP3A4—Vemurafenib—melanoma	0.0238	0.0608	CbGbCtD
Flutamide—CYP3A5—Docetaxel—melanoma	0.021	0.0535	CbGbCtD
Flutamide—CYP3A4—Docetaxel—melanoma	0.00818	0.0209	CbGbCtD
Flutamide—Metastatic neoplasm—Temozolomide—melanoma	0.00402	0.0508	CcSEcCtD
Flutamide—Proctitis—Dactinomycin—melanoma	0.00349	0.0441	CcSEcCtD
Flutamide—Metastatic neoplasm—Docetaxel—melanoma	0.00267	0.0338	CcSEcCtD
Flutamide—Traumatic liver injury—Temozolomide—melanoma	0.00207	0.0261	CcSEcCtD
Flutamide—Neoplasm malignant—Vemurafenib—melanoma	0.00177	0.0223	CcSEcCtD
Flutamide—Neoplasm—Vemurafenib—melanoma	0.00136	0.0172	CcSEcCtD
Flutamide—Transaminases increased—Carmustine—melanoma	0.00131	0.0166	CcSEcCtD
Flutamide—Bullous eruption—Docetaxel—melanoma	0.0013	0.0164	CcSEcCtD
Flutamide—Interstitial lung disease—Bleomycin—melanoma	0.00129	0.0163	CcSEcCtD
Flutamide—Interstitial lung disease—Carmustine—melanoma	0.00113	0.0142	CcSEcCtD
Flutamide—Interstitial lung disease—Temozolomide—melanoma	0.00109	0.0138	CcSEcCtD
Flutamide—Herpes zoster—Temozolomide—melanoma	0.00102	0.0129	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.000986	0.0125	CcSEcCtD
Flutamide—Ulcer—Bleomycin—melanoma	0.000966	0.0122	CcSEcCtD
Flutamide—Liver injury—Temozolomide—melanoma	0.000916	0.0116	CcSEcCtD
Flutamide—Ulcer—Dactinomycin—melanoma	0.000901	0.0114	CcSEcCtD
Flutamide—Cystitis noninfective—Bleomycin—melanoma	0.000892	0.0113	CcSEcCtD
Flutamide—Cystitis—Bleomycin—melanoma	0.000882	0.0111	CcSEcCtD
Flutamide—Photosensitivity reaction—Vemurafenib—melanoma	0.000864	0.0109	CcSEcCtD
Flutamide—Bladder pain—Bleomycin—melanoma	0.000826	0.0104	CcSEcCtD
Flutamide—Pulmonary embolism—Carmustine—melanoma	0.000798	0.0101	CcSEcCtD
Flutamide—Pulmonary embolism—Temozolomide—melanoma	0.000771	0.00974	CcSEcCtD
Flutamide—Oedema peripheral—Vemurafenib—melanoma	0.000746	0.00943	CcSEcCtD
Flutamide—Interstitial lung disease—Docetaxel—melanoma	0.000724	0.00915	CcSEcCtD
Flutamide—Neoplasm—Carmustine—melanoma	0.000721	0.00911	CcSEcCtD
Flutamide—Gynaecomastia—Carmustine—melanoma	0.000714	0.00902	CcSEcCtD
Flutamide—Neoplasm—Temozolomide—melanoma	0.000697	0.0088	CcSEcCtD
Flutamide—Diabetes mellitus—Carmustine—melanoma	0.000666	0.00841	CcSEcCtD
Flutamide—Erythema—Vemurafenib—melanoma	0.000659	0.00833	CcSEcCtD
Flutamide—Hot flush—Temozolomide—melanoma	0.000598	0.00756	CcSEcCtD
Flutamide—Menopausal symptoms—Temozolomide—melanoma	0.000593	0.00749	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000557	0.00704	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000557	0.00704	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000557	0.00704	CcSEcCtD
Flutamide—Skin disorder—Vemurafenib—melanoma	0.000523	0.0066	CcSEcCtD
Flutamide—Pulmonary embolism—Docetaxel—melanoma	0.000513	0.00648	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000504	0.00637	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000504	0.00637	CcSEcCtD
Flutamide—Haematuria—Bleomycin—melanoma	0.000487	0.00616	CcSEcCtD
Flutamide—Decreased appetite—Vemurafenib—melanoma	0.000468	0.00591	CcSEcCtD
Flutamide—Fatigue—Vemurafenib—melanoma	0.000464	0.00586	CcSEcCtD
Flutamide—Neoplasm—Docetaxel—melanoma	0.000463	0.00585	CcSEcCtD
Flutamide—Constipation—Vemurafenib—melanoma	0.00046	0.00581	CcSEcCtD
Flutamide—Hyperglycaemia—Carmustine—melanoma	0.000451	0.0057	CcSEcCtD
Flutamide—Erectile dysfunction—Temozolomide—melanoma	0.000445	0.00563	CcSEcCtD
Flutamide—Photosensitivity reaction—Temozolomide—melanoma	0.000441	0.00558	CcSEcCtD
Flutamide—Hyperglycaemia—Temozolomide—melanoma	0.000436	0.00551	CcSEcCtD
Flutamide—Hepatitis—Dactinomycin—melanoma	0.000428	0.00541	CcSEcCtD
Flutamide—Erythema—Bleomycin—melanoma	0.000399	0.00505	CcSEcCtD
Flutamide—Hot flush—Docetaxel—melanoma	0.000398	0.00503	CcSEcCtD
Flutamide—Oedema peripheral—Carmustine—melanoma	0.000395	0.00498	CcSEcCtD
Flutamide—Menopausal symptoms—Docetaxel—melanoma	0.000394	0.00498	CcSEcCtD
Flutamide—Dermatitis bullous—Docetaxel—melanoma	0.000389	0.00492	CcSEcCtD
Flutamide—Hepatitis—Temozolomide—melanoma	0.000387	0.00489	CcSEcCtD
Flutamide—Asthenia—Vemurafenib—melanoma	0.000386	0.00488	CcSEcCtD
Flutamide—Oedema peripheral—Temozolomide—melanoma	0.000381	0.00482	CcSEcCtD
Flutamide—Pruritus—Vemurafenib—melanoma	0.000381	0.00481	CcSEcCtD
Flutamide—Erythema—Dactinomycin—melanoma	0.000372	0.00471	CcSEcCtD
Flutamide—Ill-defined disorder—Bleomycin—melanoma	0.000371	0.00468	CcSEcCtD
Flutamide—Anaemia—Bleomycin—melanoma	0.000369	0.00466	CcSEcCtD
Flutamide—Diarrhoea—Vemurafenib—melanoma	0.000368	0.00465	CcSEcCtD
Flutamide—Malaise—Bleomycin—melanoma	0.00036	0.00455	CcSEcCtD
Flutamide—Leukopenia—Bleomycin—melanoma	0.000358	0.00452	CcSEcCtD
Flutamide—Dizziness—Vemurafenib—melanoma	0.000356	0.0045	CcSEcCtD
Flutamide—Erythema—Carmustine—melanoma	0.000349	0.0044	CcSEcCtD
Flutamide—Ill-defined disorder—Dactinomycin—melanoma	0.000346	0.00437	CcSEcCtD
Flutamide—Anaemia—Dactinomycin—melanoma	0.000344	0.00435	CcSEcCtD
Flutamide—Vomiting—Vemurafenib—melanoma	0.000342	0.00432	CcSEcCtD
Flutamide—Rash—Vemurafenib—melanoma	0.000339	0.00429	CcSEcCtD
Flutamide—Dermatitis—Vemurafenib—melanoma	0.000339	0.00428	CcSEcCtD
Flutamide—Headache—Vemurafenib—melanoma	0.000337	0.00426	CcSEcCtD
Flutamide—Erythema—Temozolomide—melanoma	0.000337	0.00426	CcSEcCtD
Flutamide—Discomfort—Bleomycin—melanoma	0.000336	0.00424	CcSEcCtD
Flutamide—Malaise—Dactinomycin—melanoma	0.000336	0.00424	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000335	0.00423	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000335	0.00423	CcSEcCtD
Flutamide—Leukopenia—Dactinomycin—melanoma	0.000333	0.00421	CcSEcCtD
Flutamide—Confusional state—Bleomycin—melanoma	0.000329	0.00415	CcSEcCtD
Flutamide—Oedema—Bleomycin—melanoma	0.000326	0.00412	CcSEcCtD
Flutamide—Anaemia—Carmustine—melanoma	0.000322	0.00407	CcSEcCtD
Flutamide—Nausea—Vemurafenib—melanoma	0.00032	0.00404	CcSEcCtD
Flutamide—Thrombocytopenia—Bleomycin—melanoma	0.000319	0.00403	CcSEcCtD
Flutamide—Discomfort—Dactinomycin—melanoma	0.000313	0.00396	CcSEcCtD
Flutamide—Ill-defined disorder—Temozolomide—melanoma	0.000313	0.00395	CcSEcCtD
Flutamide—Leukopenia—Carmustine—melanoma	0.000312	0.00394	CcSEcCtD
Flutamide—Anaemia—Temozolomide—melanoma	0.000311	0.00393	CcSEcCtD
Flutamide—Anorexia—Bleomycin—melanoma	0.000311	0.00393	CcSEcCtD
Flutamide—Oedema—Dactinomycin—melanoma	0.000304	0.00384	CcSEcCtD
Flutamide—Malaise—Temozolomide—melanoma	0.000304	0.00384	CcSEcCtD
Flutamide—Leukopenia—Temozolomide—melanoma	0.000302	0.00381	CcSEcCtD
Flutamide—Hypertension—Carmustine—melanoma	0.000301	0.0038	CcSEcCtD
Flutamide—Thrombocytopenia—Dactinomycin—melanoma	0.000298	0.00376	CcSEcCtD
Flutamide—Anxiety—Carmustine—melanoma	0.000296	0.00374	CcSEcCtD
Flutamide—Hypertension—Temozolomide—melanoma	0.000291	0.00368	CcSEcCtD
Flutamide—Anorexia—Dactinomycin—melanoma	0.00029	0.00366	CcSEcCtD
Flutamide—Confusional state—Carmustine—melanoma	0.000287	0.00362	CcSEcCtD
Flutamide—Anxiety—Temozolomide—melanoma	0.000286	0.00361	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000285	0.0036	CcSEcCtD
Flutamide—Oedema—Carmustine—melanoma	0.000285	0.0036	CcSEcCtD
Flutamide—Discomfort—Temozolomide—melanoma	0.000283	0.00358	CcSEcCtD
Flutamide—Decreased appetite—Bleomycin—melanoma	0.000283	0.00358	CcSEcCtD
Flutamide—Jaundice—Docetaxel—melanoma	0.000279	0.00353	CcSEcCtD
Flutamide—Thrombocytopenia—Carmustine—melanoma	0.000279	0.00352	CcSEcCtD
Flutamide—Confusional state—Temozolomide—melanoma	0.000277	0.0035	CcSEcCtD
Flutamide—Oedema—Temozolomide—melanoma	0.000275	0.00347	CcSEcCtD
Flutamide—Anorexia—Carmustine—melanoma	0.000271	0.00343	CcSEcCtD
Flutamide—Thrombocytopenia—Temozolomide—melanoma	0.000269	0.0034	CcSEcCtD
Flutamide—Feeling abnormal—Bleomycin—melanoma	0.000269	0.00339	CcSEcCtD
Flutamide—Skin disorder—Temozolomide—melanoma	0.000267	0.00337	CcSEcCtD
Flutamide—Decreased appetite—Dactinomycin—melanoma	0.000264	0.00334	CcSEcCtD
Flutamide—Fatigue—Dactinomycin—melanoma	0.000262	0.00331	CcSEcCtD
Flutamide—Anorexia—Temozolomide—melanoma	0.000262	0.00331	CcSEcCtD
Flutamide—Hepatitis—Docetaxel—melanoma	0.000257	0.00325	CcSEcCtD
Flutamide—Insomnia—Carmustine—melanoma	0.000257	0.00325	CcSEcCtD
Flutamide—Oedema peripheral—Docetaxel—melanoma	0.000254	0.0032	CcSEcCtD
Flutamide—Somnolence—Carmustine—melanoma	0.000253	0.0032	CcSEcCtD
Flutamide—Feeling abnormal—Dactinomycin—melanoma	0.000251	0.00317	CcSEcCtD
Flutamide—Insomnia—Temozolomide—melanoma	0.000249	0.00314	CcSEcCtD
Flutamide—Decreased appetite—Carmustine—melanoma	0.000247	0.00313	CcSEcCtD
Flutamide—Somnolence—Temozolomide—melanoma	0.000244	0.00309	CcSEcCtD
Flutamide—Constipation—Carmustine—melanoma	0.000243	0.00307	CcSEcCtD
Flutamide—Decreased appetite—Temozolomide—melanoma	0.000239	0.00302	CcSEcCtD
Flutamide—Fatigue—Temozolomide—melanoma	0.000237	0.003	CcSEcCtD
Flutamide—Constipation—Temozolomide—melanoma	0.000235	0.00297	CcSEcCtD
Flutamide—Feeling abnormal—Carmustine—melanoma	0.000234	0.00296	CcSEcCtD
Flutamide—Asthenia—Bleomycin—melanoma	0.000234	0.00295	CcSEcCtD
Flutamide—Pruritus—Bleomycin—melanoma	0.000231	0.00291	CcSEcCtD
Flutamide—Feeling abnormal—Temozolomide—melanoma	0.000227	0.00286	CcSEcCtD
Flutamide—Erythema—Docetaxel—melanoma	0.000224	0.00283	CcSEcCtD
Flutamide—Asthenia—Dactinomycin—melanoma	0.000218	0.00276	CcSEcCtD
Flutamide—Diarrhoea—Dactinomycin—melanoma	0.000208	0.00263	CcSEcCtD
Flutamide—Vomiting—Bleomycin—melanoma	0.000207	0.00262	CcSEcCtD
Flutamide—Anaemia—Docetaxel—melanoma	0.000207	0.00262	CcSEcCtD
Flutamide—Rash—Bleomycin—melanoma	0.000206	0.0026	CcSEcCtD
Flutamide—Dermatitis—Bleomycin—melanoma	0.000205	0.00259	CcSEcCtD
Flutamide—Asthenia—Carmustine—melanoma	0.000204	0.00258	CcSEcCtD
Flutamide—Leukopenia—Docetaxel—melanoma	0.000201	0.00253	CcSEcCtD
Flutamide—Asthenia—Temozolomide—melanoma	0.000197	0.00249	CcSEcCtD
Flutamide—Diarrhoea—Carmustine—melanoma	0.000195	0.00246	CcSEcCtD
Flutamide—Pruritus—Temozolomide—melanoma	0.000195	0.00246	CcSEcCtD
Flutamide—Nausea—Bleomycin—melanoma	0.000194	0.00245	CcSEcCtD
Flutamide—Hypertension—Docetaxel—melanoma	0.000193	0.00244	CcSEcCtD
Flutamide—Vomiting—Dactinomycin—melanoma	0.000193	0.00244	CcSEcCtD
Flutamide—Rash—Dactinomycin—melanoma	0.000192	0.00242	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000189	0.00239	CcSEcCtD
Flutamide—Dizziness—Carmustine—melanoma	0.000188	0.00238	CcSEcCtD
Flutamide—Diarrhoea—Temozolomide—melanoma	0.000188	0.00238	CcSEcCtD
Flutamide—Confusional state—Docetaxel—melanoma	0.000184	0.00233	CcSEcCtD
Flutamide—Oedema—Docetaxel—melanoma	0.000183	0.00231	CcSEcCtD
Flutamide—Dizziness—Temozolomide—melanoma	0.000182	0.0023	CcSEcCtD
Flutamide—Vomiting—Carmustine—melanoma	0.000181	0.00229	CcSEcCtD
Flutamide—Nausea—Dactinomycin—melanoma	0.000181	0.00228	CcSEcCtD
Flutamide—Rash—Carmustine—melanoma	0.000179	0.00227	CcSEcCtD
Flutamide—Dermatitis—Carmustine—melanoma	0.000179	0.00226	CcSEcCtD
Flutamide—Thrombocytopenia—Docetaxel—melanoma	0.000179	0.00226	CcSEcCtD
Flutamide—Headache—Carmustine—melanoma	0.000178	0.00225	CcSEcCtD
Flutamide—Skin disorder—Docetaxel—melanoma	0.000178	0.00224	CcSEcCtD
Flutamide—Vomiting—Temozolomide—melanoma	0.000175	0.00221	CcSEcCtD
Flutamide—Anorexia—Docetaxel—melanoma	0.000174	0.0022	CcSEcCtD
Flutamide—Rash—Temozolomide—melanoma	0.000173	0.00219	CcSEcCtD
Flutamide—Dermatitis—Temozolomide—melanoma	0.000173	0.00219	CcSEcCtD
Flutamide—Headache—Temozolomide—melanoma	0.000172	0.00218	CcSEcCtD
Flutamide—Nausea—Carmustine—melanoma	0.000169	0.00214	CcSEcCtD
Flutamide—Insomnia—Docetaxel—melanoma	0.000165	0.00209	CcSEcCtD
Flutamide—Nausea—Temozolomide—melanoma	0.000163	0.00206	CcSEcCtD
Flutamide—Somnolence—Docetaxel—melanoma	0.000163	0.00205	CcSEcCtD
Flutamide—Decreased appetite—Docetaxel—melanoma	0.000159	0.00201	CcSEcCtD
Flutamide—Fatigue—Docetaxel—melanoma	0.000158	0.00199	CcSEcCtD
Flutamide—Constipation—Docetaxel—melanoma	0.000156	0.00198	CcSEcCtD
Flutamide—Feeling abnormal—Docetaxel—melanoma	0.000151	0.0019	CcSEcCtD
Flutamide—Asthenia—Docetaxel—melanoma	0.000131	0.00166	CcSEcCtD
Flutamide—Pruritus—Docetaxel—melanoma	0.000129	0.00163	CcSEcCtD
Flutamide—Diarrhoea—Docetaxel—melanoma	0.000125	0.00158	CcSEcCtD
Flutamide—Dizziness—Docetaxel—melanoma	0.000121	0.00153	CcSEcCtD
Flutamide—Vomiting—Docetaxel—melanoma	0.000116	0.00147	CcSEcCtD
Flutamide—Rash—Docetaxel—melanoma	0.000115	0.00146	CcSEcCtD
Flutamide—Dermatitis—Docetaxel—melanoma	0.000115	0.00146	CcSEcCtD
Flutamide—Headache—Docetaxel—melanoma	0.000115	0.00145	CcSEcCtD
Flutamide—Nausea—Docetaxel—melanoma	0.000109	0.00137	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.38e-05	0.000294	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	2.37e-05	0.000294	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	2.31e-05	0.000286	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HS3ST5—melanoma	2.28e-05	0.000283	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.24e-05	0.000278	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PLCB4—melanoma	2.24e-05	0.000277	CbGpPWpGaD
Flutamide—AR—Gene Expression—HDAC2—melanoma	2.24e-05	0.000277	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.22e-05	0.000275	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PLA2G6—melanoma	2.14e-05	0.000265	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PLCB4—melanoma	2.11e-05	0.000262	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC6A11—melanoma	2.1e-05	0.00026	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIP4K2A—melanoma	2.1e-05	0.00026	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ACER3—melanoma	2.09e-05	0.000259	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—FASN—melanoma	2.07e-05	0.000257	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTAP—melanoma	2.04e-05	0.000253	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.01e-05	0.000249	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIP4K2A—melanoma	1.99e-05	0.000246	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC6A11—melanoma	1.99e-05	0.000246	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTAP—melanoma	1.93e-05	0.000239	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—VCAN—melanoma	1.92e-05	0.000238	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—UGT2B10—melanoma	1.91e-05	0.000237	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.89e-05	0.000234	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.89e-05	0.000234	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.84e-05	0.000227	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PHGDH—melanoma	1.82e-05	0.000226	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—LUM—melanoma	1.82e-05	0.000226	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.82e-05	0.000225	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HPSE—melanoma	1.79e-05	0.000221	CbGpPWpGaD
Flutamide—AR—Gene Expression—CDKN2B—melanoma	1.79e-05	0.000221	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HS3ST5—melanoma	1.78e-05	0.00022	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.76e-05	0.000218	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CUBN—melanoma	1.75e-05	0.000217	CbGpPWpGaD
Flutamide—AR—Gene Expression—VDR—melanoma	1.74e-05	0.000216	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PLCB4—melanoma	1.73e-05	0.000214	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—LUM—melanoma	1.72e-05	0.000213	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PHGDH—melanoma	1.72e-05	0.000213	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	1.7e-05	0.00021	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—BSG—melanoma	1.69e-05	0.00021	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SDHD—melanoma	1.69e-05	0.00021	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CSPG4—melanoma	1.69e-05	0.00021	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HPSE—melanoma	1.69e-05	0.000209	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CUBN—melanoma	1.66e-05	0.000205	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GPAM—melanoma	1.64e-05	0.000203	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIP4K2A—melanoma	1.62e-05	0.000201	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC6A11—melanoma	1.62e-05	0.000201	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP17A1—melanoma	1.62e-05	0.000201	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ACER3—melanoma	1.61e-05	0.0002	CbGpPWpGaD
Flutamide—AR—Gene Expression—PRKCA—melanoma	1.61e-05	0.000199	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SDHD—melanoma	1.6e-05	0.000198	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—BSG—melanoma	1.6e-05	0.000198	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CSPG4—melanoma	1.6e-05	0.000198	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.6e-05	0.000198	CbGpPWpGaD
Flutamide—AR—Gene Expression—ERCC2—melanoma	1.59e-05	0.000197	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTAP—melanoma	1.58e-05	0.000196	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.58e-05	0.000196	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GPAM—melanoma	1.55e-05	0.000192	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.54e-05	0.000191	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GNA11—melanoma	1.53e-05	0.00019	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—FASN—melanoma	1.5e-05	0.000186	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—UGT2B10—melanoma	1.47e-05	0.000183	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SLC5A5—melanoma	1.47e-05	0.000183	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—melanoma	1.44e-05	0.000178	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.43e-05	0.000177	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GNAQ—melanoma	1.42e-05	0.000176	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CD44—melanoma	1.42e-05	0.000176	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PHGDH—melanoma	1.41e-05	0.000175	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—LUM—melanoma	1.41e-05	0.000175	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PLA2G6—melanoma	1.4e-05	0.000173	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.39e-05	0.000173	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.38e-05	0.000171	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HPSE—melanoma	1.38e-05	0.000171	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HS3ST5—melanoma	1.37e-05	0.00017	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CUBN—melanoma	1.36e-05	0.000168	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PLCB4—melanoma	1.35e-05	0.000167	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	1.32e-05	0.000164	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PLA2G6—melanoma	1.32e-05	0.000163	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—BSG—melanoma	1.31e-05	0.000162	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CSPG4—melanoma	1.31e-05	0.000162	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SDHD—melanoma	1.31e-05	0.000162	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH1—melanoma	1.29e-05	0.000159	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GPAM—melanoma	1.27e-05	0.000157	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC6A11—melanoma	1.27e-05	0.000157	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIP4K2A—melanoma	1.27e-05	0.000157	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—VCAN—melanoma	1.25e-05	0.000155	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTAP—melanoma	1.23e-05	0.000153	CbGpPWpGaD
Flutamide—AR—Gene Expression—PPARG—melanoma	1.21e-05	0.00015	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.2e-05	0.000149	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.2e-05	0.000149	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—VCAN—melanoma	1.18e-05	0.000147	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ABCB1—melanoma	1.12e-05	0.000139	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.12e-05	0.000139	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PHGDH—melanoma	1.1e-05	0.000136	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—LUM—melanoma	1.1e-05	0.000136	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.08e-05	0.000134	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PLA2G6—melanoma	1.08e-05	0.000134	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HPSE—melanoma	1.08e-05	0.000133	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP17A1—melanoma	1.06e-05	0.000131	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CUBN—melanoma	1.06e-05	0.000131	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PLCB4—melanoma	1.04e-05	0.000129	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PRKCA—melanoma	1.03e-05	0.000128	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ERCC2—melanoma	1.03e-05	0.000127	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CSPG4—melanoma	1.02e-05	0.000126	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—BSG—melanoma	1.02e-05	0.000126	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SDHD—melanoma	1.02e-05	0.000126	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP17A1—melanoma	9.99e-06	0.000124	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GNA11—melanoma	9.98e-06	0.000124	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GPAM—melanoma	9.88e-06	0.000122	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.85e-06	0.000122	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC6A11—melanoma	9.77e-06	0.000121	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIP4K2A—melanoma	9.77e-06	0.000121	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—FASN—melanoma	9.77e-06	0.000121	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	9.73e-06	0.000121	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—VCAN—melanoma	9.69e-06	0.00012	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC5A5—melanoma	9.61e-06	0.000119	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTAP—melanoma	9.5e-06	0.000118	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GNA11—melanoma	9.43e-06	0.000117	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GNAQ—melanoma	9.28e-06	0.000115	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CD44—melanoma	9.28e-06	0.000115	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—FASN—melanoma	9.23e-06	0.000114	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.17e-06	0.000114	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC5A5—melanoma	9.08e-06	0.000113	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1B1—melanoma	8.9e-06	0.00011	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.85e-06	0.00011	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CD44—melanoma	8.77e-06	0.000109	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GNAQ—melanoma	8.77e-06	0.000109	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.59e-06	0.000106	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.51e-06	0.000105	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.5e-06	0.000105	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PHGDH—melanoma	8.47e-06	0.000105	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—LUM—melanoma	8.47e-06	0.000105	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP1B1—melanoma	8.41e-06	0.000104	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PLA2G6—melanoma	8.4e-06	0.000104	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HPSE—melanoma	8.31e-06	0.000103	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP17A1—melanoma	8.17e-06	0.000101	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CUBN—melanoma	8.15e-06	0.000101	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CG—melanoma	8.1e-06	0.0001	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.06e-06	9.99e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	7.96e-06	9.86e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CSPG4—melanoma	7.88e-06	9.76e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—BSG—melanoma	7.88e-06	9.76e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SDHD—melanoma	7.88e-06	9.76e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPARG—melanoma	7.82e-06	9.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GNA11—melanoma	7.72e-06	9.57e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPAM—melanoma	7.63e-06	9.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—FASN—melanoma	7.55e-06	9.36e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—VCAN—melanoma	7.55e-06	9.35e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC5A5—melanoma	7.43e-06	9.21e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.42e-06	9.19e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCB1—melanoma	7.33e-06	9.08e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GNAQ—melanoma	7.18e-06	8.89e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CD44—melanoma	7.18e-06	8.89e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.15e-06	8.85e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CD—melanoma	7.12e-06	8.83e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MAPK3—melanoma	7.12e-06	8.82e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALB—melanoma	7.03e-06	8.71e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.03e-06	8.71e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.96e-06	8.63e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCB1—melanoma	6.92e-06	8.58e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—melanoma	6.92e-06	8.58e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.9e-06	8.55e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1B1—melanoma	6.88e-06	8.53e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PRKCA—melanoma	6.74e-06	8.36e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ERCC2—melanoma	6.69e-06	8.29e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PLA2G6—melanoma	6.49e-06	8.04e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PRKCA—melanoma	6.37e-06	7.9e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP17A1—melanoma	6.37e-06	7.89e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ERCC2—melanoma	6.32e-06	7.83e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.28e-06	7.78e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CB—melanoma	6.21e-06	7.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.2e-06	7.68e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—melanoma	6.15e-06	7.62e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.07e-06	7.52e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNA11—melanoma	6.01e-06	7.45e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—FASN—melanoma	5.89e-06	7.29e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—VCAN—melanoma	5.83e-06	7.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC5A5—melanoma	5.79e-06	7.17e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCB1—melanoma	5.67e-06	7.02e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNAQ—melanoma	5.59e-06	6.93e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CD44—melanoma	5.59e-06	6.93e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.48e-06	6.78e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.42e-06	6.72e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—melanoma	5.37e-06	6.65e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1B1—melanoma	5.36e-06	6.64e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—melanoma	5.28e-06	6.55e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.23e-06	6.49e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PRKCA—melanoma	5.21e-06	6.46e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ERCC2—melanoma	5.17e-06	6.41e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARG—melanoma	5.1e-06	6.32e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—melanoma	4.99e-06	6.18e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP17A1—melanoma	4.92e-06	6.09e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARG—melanoma	4.82e-06	5.97e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—melanoma	4.8e-06	5.95e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.73e-06	5.86e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CD—melanoma	4.64e-06	5.75e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNA11—melanoma	4.64e-06	5.75e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALB—melanoma	4.58e-06	5.68e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—FASN—melanoma	4.54e-06	5.63e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC5A5—melanoma	4.47e-06	5.54e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCB1—melanoma	4.41e-06	5.47e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CD—melanoma	4.39e-06	5.44e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALB—melanoma	4.33e-06	5.37e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNAQ—melanoma	4.32e-06	5.35e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CD44—melanoma	4.32e-06	5.35e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.28e-06	5.31e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1B1—melanoma	4.14e-06	5.13e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CG—melanoma	4.08e-06	5.06e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PRKCA—melanoma	4.06e-06	5.03e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CB—melanoma	4.05e-06	5.02e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ERCC2—melanoma	4.03e-06	4.99e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—melanoma	4.01e-06	4.97e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARG—melanoma	3.94e-06	4.88e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CB—melanoma	3.82e-06	4.74e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—melanoma	3.79e-06	4.7e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—melanoma	3.79e-06	4.69e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CD—melanoma	3.59e-06	4.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALB—melanoma	3.54e-06	4.39e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—melanoma	3.5e-06	4.33e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCB1—melanoma	3.41e-06	4.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.34e-06	4.14e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—melanoma	3.3e-06	4.09e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CG—melanoma	3.18e-06	3.94e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PRKCA—melanoma	3.14e-06	3.89e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CB—melanoma	3.13e-06	3.88e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ERCC2—melanoma	3.11e-06	3.85e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—melanoma	3.1e-06	3.84e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—melanoma	3.09e-06	3.83e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARG—melanoma	3.07e-06	3.81e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CD—melanoma	2.8e-06	3.47e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALB—melanoma	2.76e-06	3.42e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—melanoma	2.7e-06	3.35e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—melanoma	2.47e-06	3.06e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CG—melanoma	2.46e-06	3.04e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CB—melanoma	2.44e-06	3.02e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—melanoma	2.42e-06	2.99e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARG—melanoma	2.37e-06	2.94e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—melanoma	2.33e-06	2.89e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CD—melanoma	2.16e-06	2.68e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALB—melanoma	2.13e-06	2.64e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—melanoma	2.11e-06	2.61e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—melanoma	2.02e-06	2.5e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—melanoma	1.91e-06	2.36e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—melanoma	1.9e-06	2.36e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CB—melanoma	1.88e-06	2.33e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—melanoma	1.86e-06	2.31e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—melanoma	1.63e-06	2.02e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—melanoma	1.56e-06	1.93e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—melanoma	1.49e-06	1.84e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—melanoma	1.21e-06	1.5e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—melanoma	1.15e-06	1.42e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—melanoma	9.37e-07	1.16e-05	CbGpPWpGaD
